Aspirin Plus PPI Prevents Esophageal Cancer.
Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to the results of a major phase 3 chemoprevention trial from the United Kingdom, the Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia (AspECT) trial. Dr Janusz… Read More »Aspirin Plus PPI Prevents Esophageal Cancer.